Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer
The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/durvalumab-plus-bcg-earns-fda-nod-bladder-cancer-2026a1000hv5?src=rss Author ...





















